New Interim Analysis From Observational Study Suggests That Delivery of Insulin Via Valeritas' V-Go Shows Promise in Improving Glycemic Control for Patients With Type 2 Diabetes
5/3/2013 9:25:37 AM
More...
|
Valeritas Selects dLife's New Diabetes Patient Engagement Solution for Valeritas' V-go Disposable Insulin Delivery Device
5/22/2012 11:29:10 AM
More...
|
Valeritas Replaces Complicated Client/Server CRM with Intuitive Veeva Systems, Inc. CRM in the Cloud
4/25/2012 10:33:02 AM
More...
|
Valeritas Announces $150 Million Financing
9/12/2011 6:58:20 AM
More...
|
Valeritas Receives European CE Mark Approval for the V-Go(TM) Disposable Insulin Delivery Device
7/25/2011 6:20:19 AM
More...
|
Valeritas Receives FDA 510(k) Clearance for the V-Go(TM) Disposable Insulin Delivery Device for Use with NovoLog(R)
3/1/2011 6:18:56 AM
More...
|
Valeritas Receives FDA 510(k) Clearance for the V-Go Disposable Insulin Delivery Device
12/8/2010 6:23:10 AM
More...
|
Valeritas Announces Appointment of New CEO
6/1/2009 9:23:50 AM
More...
|
Valeritas Secures $50 Million
11/10/2008 7:20:48 AM
More...
|
Valeritas Announces Brand Name V-Go(TM) for Disposable Insulin Delivery Device
11/1/2007 9:23:25 AM
More...
|
|